For: | Cibor D, Owczarek D, Butenas S, Salapa K, Mach T, Undas A. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases. World J Gastroenterol 2017; 23(26): 4796-4805 [PMID: 28765701 DOI: 10.3748/wjg.v23.i26.4796] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v23/i26/4796.htm |
Number | Citing Articles |
1 |
Andrea Boccatonda, Marco Balletta, Susanna Vicari, Ariela Hoxha, Paolo Simioni, Elena Campello. The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review. Seminars in Thrombosis and Hemostasis 2023; 49(07): 744 doi: 10.1055/s-0042-1758869
|
2 |
Célia Schellenberg, Jérémy Lagrange, Muhammad Usman Ahmed, Djésia Arnone, Philippe Campoli, Huguette Louis, Nina Touly, Bénédicte Caron, François Plénat, Julien Perrin, Peter J Lenting, Véronique Regnault, Patrick Lacolley, Cécile V Denis, Laurent Peyrin-Biroulet. The Role of Platelets and von Willebrand Factor in the Procoagulant Phenotype of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2024; 18(5): 751 doi: 10.1093/ecco-jcc/jjad198
|
3 |
Adriana Ribas Andrade, Tania Rubia Flores da Rocha, Carmen Lucia Ortiz-Agostinho, Iêda Nishitokukado, Alexandre Sousa Carlos, Matheus Freitas Cardoso de Azevedo, Claudio Lioshi Hashimoto, Aderson Omar Moura Cintra Damião, Flair José Carrilho, Elbio D’Amico, Aytan Miranda Sipahi, André Zonetti de Arruda Leite. Endoscopic activity, tissue factor and Crohn’s disease: findings in clinical remission patients. Therapeutic Advances in Gastroenterology 2020; 13: 175628482093941 doi: 10.1177/1756284820939412
|
4 |
Cheng Xu, Zhen Song, Li-ting Hu, Yi-heng Tong, Jing-yi Hu, Hong Shen. Abnormal platelet parameters in inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03305-9
|
5 |
Monica Bray, Melda A. Guzel, Fong Lam, Andrew Yee, Miguel A. Cruz, Rolando E. Rumbaut. High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19. Journal of Thrombosis and Thrombolysis 2022; 54(2): 211 doi: 10.1007/s11239-022-02679-5
|
6 |
Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Polyzos, Christos Liatsos, Maria Tzitiridou-Chatzopoulou, Dimitrios Chatzopoulos, Elisabeth Vardaka, Dimitra Gialamprinou, Georgios Kotronis, Tharshika Thavayogarajah, Michael Doulberis. Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2023; 68(2): 701 doi: 10.1007/s10620-022-07642-1
|
7 |
Emmanuel J. Favaloro. The Role of the von Willebrand Factor Collagen-Binding Assay (VWF:CB) in the Diagnosis and Treatment of von Willebrand Disease (VWD) and Way Beyond: A Comprehensive 36-Year History
. Seminars in Thrombosis and Hemostasis 2024; 50(01): 043 doi: 10.1055/s-0043-1763259
|
8 |
Jie Xu, Jun He, Ya-Li Zhou, Zhen Weng, Ming Li, Zhen-Xin Wang, Yang He. Von Willebrand factor promotes radiation-induced intestinal injury (RIII) development and its cleavage enzyme rhADAMTS13 protects against RIII by reducing inflammation and oxidative stress. Free Radical Biology and Medicine 2024; 210: 1 doi: 10.1016/j.freeradbiomed.2023.11.004
|
9 |
Jeremy Lagrange, Patrick Lacolley, Denis Wahl, Laurent Peyrin-Biroulet, Véronique Regnault. Shedding Light on Hemostasis in Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2021; 19(6): 1088 doi: 10.1016/j.cgh.2019.12.043
|
10 |
Alison Michels, David Lillicrap, Michael Yacob. Role of von Willebrand factor in venous thromboembolic disease. JVS-Vascular Science 2022; 3: 17 doi: 10.1016/j.jvssci.2021.08.002
|
11 |
Jérémy Lagrange, Muhammad Usman Ahmed, Djésia Arnone, Patrick Lacolley, Véronique Regnault, Laurent Peyrin-Biroulet, Cécile V Denis. Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae142
|